When Paranoia Comes with the Treatment: Psychosis Associated with Tacrolimus Use
- PMID: 34595211
- PMCID: PMC8436620
- DOI: 10.1159/000515048
When Paranoia Comes with the Treatment: Psychosis Associated with Tacrolimus Use
Abstract
Tacrolimus is an immunosuppressive drug frequently used in solid organ transplant recipients. This drug has well-documented neuropsychiatric side effects in the literature, although emergence of psychotic symptoms is rare, being only described in a very few case reports. We present a case of a renal transplant recipient with no prior psychiatric history, who developed a severe psychosis secondary to supratherapeutic tacrolimus' blood concentrations. This case highlights the importance of clinical awareness to rare but severe neuropsychiatric effects due to tacrolimus use.
Keywords: Neuropsychiatric side effects; Neurotoxic; Psychosis; Tacrolimus.
Copyright © 2021 by S. Karger AG, Basel.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
References
-
- Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL, et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991;66((4)):807–15. - PubMed
-
- Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004;43((43)):623–53. - PubMed
-
- Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int. 2000;13((5)):313–26. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
